Ginkgo Bioworks Holdings Operating Margin 2020-2022 | DNA
Current and historical operating margin for Ginkgo Bioworks Holdings (DNA) over the last 10 years. The current operating profit margin for Ginkgo Bioworks Holdings as of March 31, 2022 is 0.00%.
Ginkgo Bioworks Holdings Operating Margin Historical Data |
Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
2021-12-31 |
$0.31B |
$-1.83B |
-582.17% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$4.228B |
$0.314B |
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|